Latest Insider Transactions at Surmodics Inc (SRDX)
This section provides a real-time view of insider transactions for Surmodics Inc (SRDX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of SURMODICS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of SURMODICS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 12
2021
|
Gordon S. Weber Sr. VP of Legal, GC and Sec. |
SELL
Payment of exercise price or tax liability
|
Direct |
292
-4.03%
|
$15,184
$52.99 P/Share
|
|
Apr 28
2021
|
Charles W Olson SVP, Medical Device Coatings |
SELL
Open market or private sale
|
Direct |
1,508
-3.58%
|
$88,972
$59.75 P/Share
|
|
Apr 16
2021
|
Charles W Olson SVP, Medical Device Coatings |
SELL
Open market or private sale
|
Direct |
648
-1.52%
|
$38,232
$59.75 P/Share
|
|
Mar 31
2021
|
Charles W Olson SVP, Medical Device Coatings |
SELL
Open market or private sale
|
Direct |
4,759
-10.02%
|
$266,504
$56.75 P/Share
|
|
Mar 31
2021
|
David Dantzker |
BUY
Grant, award, or other acquisition
|
Direct |
334
+1.1%
|
$18,704
$56.07 P/Share
|
|
Mar 31
2021
|
Ronald B Sr Kalich |
BUY
Grant, award, or other acquisition
|
Direct |
318
+1.43%
|
$17,808
$56.07 P/Share
|
|
Mar 01
2021
|
Gary R Maharaj President & CEO |
SELL
Open market or private sale
|
Direct |
4,000
-1.19%
|
$208,000
$52.26 P/Share
|
|
Feb 26
2021
|
Susan E Knight |
SELL
Open market or private sale
|
Direct |
5,576
-16.26%
|
$289,952
$52.36 P/Share
|
|
Feb 26
2021
|
Susan E Knight |
BUY
Exercise of conversion of derivative security
|
Direct |
5,576
+13.99%
|
$117,096
$21.31 P/Share
|
|
Feb 26
2021
|
Charles W Olson SVP, Medical Device Coatings |
SELL
Payment of exercise price or tax liability
|
Direct |
9,139
-16.14%
|
$475,228
$52.15 P/Share
|
|
Feb 26
2021
|
Charles W Olson SVP, Medical Device Coatings |
BUY
Exercise of conversion of derivative security
|
Direct |
13,533
+11.03%
|
$270,660
$20.64 P/Share
|
|
Feb 24
2021
|
Timothy J. Arens Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,444
-11.44%
|
$379,644
$51.7 P/Share
|
|
Feb 24
2021
|
Timothy J. Arens Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,973
+7.89%
|
$219,460
$20.64 P/Share
|
|
Feb 23
2021
|
Jose H Bedoya |
SELL
Open market or private sale
|
Direct |
1,497
-6.16%
|
$74,850
$50.68 P/Share
|
|
Feb 16
2021
|
Joseph J. Stich SVP of HR, President IVD |
SELL
Open market or private sale
|
Direct |
2,500
-2.49%
|
$130,000
$52.0 P/Share
|
|
Feb 12
2021
|
Nusrath Sultana VP, Clinical Affairs |
SELL
Payment of exercise price or tax liability
|
Direct |
449
-6.4%
|
$23,797
$53.17 P/Share
|
|
Feb 12
2021
|
Ronald B Sr Kalich |
SELL
Payment of exercise price or tax liability
|
Direct |
1,900
-8.08%
|
$100,700
$53.17 P/Share
|
|
Feb 12
2021
|
Ronald B Sr Kalich |
BUY
Exercise of conversion of derivative security
|
Direct |
4,098
+14.85%
|
$106,548
$26.46 P/Share
|
|
Feb 11
2021
|
Jose H Bedoya |
BUY
Grant, award, or other acquisition
|
Direct |
1,067
+4.2%
|
-
|
|
Feb 11
2021
|
David Dantzker |
BUY
Grant, award, or other acquisition
|
Direct |
1,067
+3.46%
|
-
|
|
Feb 11
2021
|
Lisa Wipperman Heine |
BUY
Grant, award, or other acquisition
|
Direct |
1,067
+11.4%
|
-
|
|
Feb 11
2021
|
Ronald B Sr Kalich |
BUY
Grant, award, or other acquisition
|
Direct |
1,067
+5.21%
|
-
|
|
Feb 11
2021
|
Susan E Knight |
BUY
Grant, award, or other acquisition
|
Direct |
1,151
+3.85%
|
-
|
|
Feb 11
2021
|
Gary R Maharaj President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
56,152
-25.02%
|
$2,976,056
$53.86 P/Share
|
|
Feb 11
2021
|
Gary R Maharaj President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
82,264
+12.04%
|
$1,727,544
$21.74 P/Share
|
|
Feb 01
2021
|
Gary R Maharaj President & CEO |
SELL
Open market or private sale
|
Direct |
3,000
-1.03%
|
$135,000
$45.16 P/Share
|
|
Jan 05
2021
|
Joseph J. Stich SVP of HR, President IVD |
SELL
Open market or private sale
|
Direct |
2,500
-4.71%
|
$112,500
$45.0 P/Share
|
|
Jan 04
2021
|
Gary R Maharaj President & CEO |
SELL
Open market or private sale
|
Direct |
2,000
-1.36%
|
$86,000
$43.96 P/Share
|
|
Dec 31
2020
|
David Dantzker |
BUY
Grant, award, or other acquisition
|
Direct |
430
+1.47%
|
$18,490
$43.52 P/Share
|
|
Dec 31
2020
|
Ronald B Sr Kalich |
BUY
Grant, award, or other acquisition
|
Direct |
410
+2.19%
|
$17,630
$43.52 P/Share
|
|
Nov 30
2020
|
Timothy J. Arens Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,273
+7.32%
|
-
|
|
Nov 30
2020
|
Gary R Maharaj President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
17,361
+10.55%
|
-
|
|
Nov 30
2020
|
John D. Manders Corporate Controller |
BUY
Grant, award, or other acquisition
|
Direct |
667
+18.03%
|
-
|
|
Nov 30
2020
|
Charles W Olson SVP, Medical Device Coatings |
BUY
Grant, award, or other acquisition
|
Direct |
4,273
+9.02%
|
-
|
|
Nov 30
2020
|
Teri Woodwick Sides SVP, Vascular Interventions |
BUY
Grant, award, or other acquisition
|
Direct |
4,273
+20.09%
|
-
|
|
Nov 30
2020
|
Joseph J. Stich SVP of HR, President IVD |
BUY
Grant, award, or other acquisition
|
Direct |
4,273
+7.45%
|
-
|
|
Nov 30
2020
|
Nusrath Sultana VP, Clinical Affairs |
BUY
Grant, award, or other acquisition
|
Direct |
3,739
+34.77%
|
-
|
|
Nov 30
2020
|
Gordon S. Weber Sr. VP of Legal, GC and Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
4,273
+37.79%
|
-
|
|
Nov 28
2020
|
Charles W Olson SVP, Medical Device Coatings |
SELL
Payment of exercise price or tax liability
|
Direct |
596
-1.51%
|
$22,648
$38.36 P/Share
|
|
Nov 28
2020
|
Joseph J. Stich SVP of HR, President IVD |
SELL
Payment of exercise price or tax liability
|
Direct |
741
-1.5%
|
$28,158
$38.36 P/Share
|
|
Nov 28
2020
|
Gary R Maharaj President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,969
-1.49%
|
$74,822
$38.36 P/Share
|
|
Nov 28
2020
|
Timothy J. Arens Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
596
-1.18%
|
$22,648
$38.36 P/Share
|
|
Nov 27
2020
|
Charles W Olson SVP, Medical Device Coatings |
SELL
Payment of exercise price or tax liability
|
Direct |
349
-0.88%
|
$13,262
$38.36 P/Share
|
|
Nov 27
2020
|
Joseph J. Stich SVP of HR, President IVD |
SELL
Payment of exercise price or tax liability
|
Direct |
434
-0.87%
|
$16,492
$38.36 P/Share
|
|
Nov 27
2020
|
Teri Woodwick Sides SVP, Vascular Interventions |
SELL
Payment of exercise price or tax liability
|
Direct |
1,711
-11.86%
|
$65,018
$38.36 P/Share
|
|
Nov 27
2020
|
John D. Manders Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
45
-1.87%
|
$1,710
$38.36 P/Share
|
|
Nov 27
2020
|
Gary R Maharaj President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,477
-1.11%
|
$56,126
$38.36 P/Share
|
|
Nov 27
2020
|
Timothy J. Arens Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
349
-0.69%
|
$13,262
$38.36 P/Share
|
|
Nov 25
2020
|
Charles W Olson SVP, Medical Device Coatings |
SELL
Payment of exercise price or tax liability
|
Direct |
471
-1.17%
|
$17,898
$38.93 P/Share
|
|
Nov 25
2020
|
Joseph J. Stich SVP of HR, President IVD |
SELL
Payment of exercise price or tax liability
|
Direct |
586
-1.16%
|
$22,268
$38.93 P/Share
|